This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 14-17, 2024 | In-Person + Digital
Boston, MA, USAHynes Convention Center

Thazha P. Prakash, Ph.D.
Executive Research Fellow at Ionis Pharmaceuticals


Executive Director of Medicinal Chemistry at Ionis Pharmaceuticals Inc. Co-inventor of LICA technology for antisense therapeutics. Involved in development of Gen 2 and Gen 2.5 chemistries for antisense drugs and led Ionis ss-siRNA and siRNA programs. Developed simplified synthetic RNA for CRISPR based genome editing. Contributed to early research on discovery of anti HCV drugs. Ph. D. in Organic Chemistry from University of Pune, Pune, India. Postdoctoral training at the University of California, Riverside, California and at the Ionis Pharmaceuticals, Carlsbad, California. Listed as co-author/co-inventor on more than 225 peer-reviewed publications, issued patents and patent applications.

Agenda Sessions

  • Medicinal Chemistry Approaches to Identify Long Acting ApoC3 siRNA Candidates